Cargando…

Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers

SIMPLE SUMMARY: Female Lynch syndrome (LS) carriers have an increased risk to develop endometrial and ovarian cancer. In the Netherlands, carriers are therefore advised annual gynecological surveillance and eventually, risk-reducing surgery. Global gynecological LS surveillance guidelines are scarce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eikenboom, Ellis L., van Doorn, Helena C., Dinjens, Winand N. M., Dubbink, Hendrikus J., Geurts-Giele, Willemina R. R., Spaander, Manon C. W., Tops, Carli M. J., Wagner, Anja, Goverde, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865882/ https://www.ncbi.nlm.nih.gov/pubmed/33530354 http://dx.doi.org/10.3390/cancers13030459

Ejemplares similares

Unexplained mismatch repair deficiency: Case closed
por: Eikenboom, Ellis L., et al.
Publicado: (2022)

Mitochondrial D310 mutation as clonal marker for solid tumors
por: Geurts-Giele, Willemina R. R., et al.
Publicado: (2015)

Somatic mosaicism by a de novo MLH1 mutation as a cause of Lynch syndrome
por: Geurts‐Giele, Willemina R., et al.
Publicado: (2019)

Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers
por: Goverde, A., et al.
Publicado: (2017)

A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory
por: Van Lier, Margot GF, et al.
Publicado: (2010)

Novel EGFR V834L Germline Mutation Associated With Familial Lung Adenocarcinoma
por: van der Leest, Cor, et al.
Publicado: (2018)

“The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology”: letter to the Editor
por: Dinjens, Winand N. M., et al.
Publicado: (2020)

Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity
por: Houlleberghs, Hellen, et al.
Publicado: (2017)

HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows
por: Huijsmans, Cornelis Johannes Jacobus, et al.
Publicado: (2016)

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation
por: Groenendijk, Floris H., et al.
Publicado: (2010)

Updates in gynecologic care for individuals with lynch syndrome
por: Underkofler, Kaylee A., et al.
Publicado: (2023)

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples
por: Mankor, Joanne M., et al.
Publicado: (2020)

Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers
por: Etchegary, Holly, et al.
Publicado: (2015)

Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics
por: Eijkelenboom, Astrid, et al.
Publicado: (2019)

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
por: Synhaeve, Nathalie E., et al.
Publicado: (2018)

Synchronous gynecologic malignancy and preliminary results of Lynch syndrome
por: Kim, Min Kyu, et al.
Publicado: (2011)

Liquid Biopsies for Colorectal Cancer and Advanced Adenoma Screening and Surveillance: What to Measure?
por: Eikenboom, Ellis L., et al.
Publicado: (2023)

Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts
por: Talseth-Palmer, Bente A, et al.
Publicado: (2012)

Screening and identification of Lynch syndrome: a systematic review of the frequency of Lynch syndrome-associated clinicopathologic and molecular characteristics in Lynch syndrome gynecologic cancers
por: Yang, Zihui, et al.
Publicado: (2021)

Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database
por: Dominguez-Valentin, Mev, et al.
Publicado: (2020)

Excluding Lynch syndrome in a female patient with metachronous DNA mismatch repair deficient colon- and ovarian cancer
por: Crobach, Stijn, et al.
Publicado: (2017)

Lynch syndrome – Muir-Torre variant: implication in gynecologic oncology
por: Bogani, Giorgio, et al.
Publicado: (2018)

Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer
por: Capasso, Ilaria, et al.
Publicado: (2023)

SNP association study in PMS2-associated Lynch syndrome
por: ten Broeke, Sanne W., et al.
Publicado: (2017)

TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer
por: Vitale, Silvia R., et al.
Publicado: (2020)

Mucinous carcinoid of the ovary: report of a case with metastasis in the contralateral ovary after ten years
por: Buis, Christien C.M, et al.
Publicado: (2010)

Early onset esophageal adenocarcinoma: a distinct molecular entity?
por: van Nistelrooij, Anna M.J., et al.
Publicado: (2016)

Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals
por: Dueñas, Nuria, et al.
Publicado: (2020)

The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
por: Crosbie, Emma J., et al.
Publicado: (2019)

Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma
por: Wijnenga, Maarten M. J., et al.
Publicado: (2018)

Prevalence of c-KIT Mutations in Gonadoblastoma and Dysgerminomas of Patients with Disorders of Sex Development (DSD) and Ovarian Dysgerminomas
por: Hersmus, Remko, et al.
Publicado: (2012)

Identification of Lynch Syndrome Carriers among Patients with Small Bowel Adenocarcinoma
por: Sánchez, Ariadna, et al.
Publicado: (2021)

Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers
por: Jansen, Anne ML, et al.
Publicado: (2016)

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA
por: Bos, Manouk K., et al.
Publicado: (2020)

Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the ‘Dutch Gynecological Oncology Audit’
por: Algera, M.D., et al.
Publicado: (2022)

Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers
por: Cuadros, Marta, et al.
Publicado: (2022)

Colorectal surveillance outcomes from an institutional longitudinal cohort of lynch syndrome carriers
por: del Carmen, Gabriel, et al.
Publicado: (2023)

Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases
por: Lotsari, Johanna E, et al.
Publicado: (2012)

Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers
por: Kim, Byung Wook, et al.
Publicado: (2021)

Gynecological Cancers in Lynch Syndrome: A Comparison of the Histological Features with Sporadic Cases of the General Population
por: Bounous, Valentina Elisabetta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4hj8823ikofo6acbpn71tu3q4b